Target intelligence / Profile preview

Zaire ebolavirus envelope glycoprotein (GP)

Target
GP
Molecular classification
Viral protein, Envelope glycoprotein
01

Overview

The envelope glycoprotein (GP) of Zaire ebolavirus is the sole viral protein expressed on the surface of the virion. It is essential for virus entry into host cells, mediating both attachment to cellular receptors and fusion between viral and host membranes. The GP exists as a trimeric complex composed of two subunits: GP1 and GP2, which are generated by post-translational proteolytic cleavage of a single precursor polypeptide. GP1 functions primarily in receptor binding and contains a glycan cap and mucin-like domain that shield conserved regions from immune recognition. GP2 is responsible for membrane fusion. Upon activation, it undergoes conformational changes exposing its hydrophobic fusion loop, facilitating merger with host membranes. It also downregulates expression of several host cell adhesion molecules (integrins), contributing to vascular leakage seen in Ebola hemorrhagic fever; also modulates immune responses by interacting with TLR4.

02

Mechanism of action

Neutralizing antibodies block conformational changes required for membrane fusion.

03

Biological functions

Viral attachmentViral entryMembrane fusionImmune evasionModulation of host cell adhesionModulation of host immunity
04

Disease associations

InfectionEbola hemorrhagic feverVascular leakage
05

Safety considerations

Immune evasion through glycosylationModulation of host immunity complicates therapeutic strategies

Beyond the preview

Go deeper on Zaire ebolavirus envelope glycoprotein (GP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zaire ebolavirus envelope glycoprotein (GP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call